MGRX · Mangoceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Cohen Jacob D. Chief Executive Officer | ▼ Sell | Gift | 3,305,000 Shares held | 8/11/2026 | View profile |
| JOHNSTON EUGENE M CFO | ▲ Buy | Grant | 220,000 Shares held | 7/28/2026 | View profile |
| Hammer Amanda Elizabeth Chief Operating Officer | ▲ Buy | Grant | 175,000 Shares held | 6/3/2024 | View profile |
| D'Alessio Lorraine Pamela Director | ▲ Buy | Grant | 136,667 Shares held | 9/9/2025 | View profile |
| MYERS KENNY Director | ▲ Buy | Grant | 136,667 Shares held | 9/9/2025 | View profile |
| Alex P. Hamilton Director | ▲ Buy | Grant | 101,667 Shares held | 7/28/2026 | View profile |
| Isaac Antonios President | ▲ Buy | Grant | 60,000 Shares held | 4/10/2025 | View profile |
Transaction History
| Cohen Jacob D. | ▼ Sell | Gift | 2,000,000 | $0 | 8/11/2026 |
| Cohen Jacob D. | ▼ Sell | Gift | 2,000,000 | $0 | 8/11/2026 |
| Cohen Jacob D. | ▲ Buy | Grant | 2,000,000 | $0 | 7/28/2026 |
| JOHNSTON EUGENE M | ▲ Buy | Grant | 100,000 | $0 | 7/28/2026 |
| Alex P. Hamilton | ▲ Buy | Grant | 100,000 | $0 | 7/28/2026 |
| JOHNSTON EUGENE M | ▼ Sell | Open Market | 3,333 | $4K | 12/15/2025 |
| JOHNSTON EUGENE M | ▼ Sell | Open Market | 5,000 | $6K | 12/9/2025 |
| JOHNSTON EUGENE M | ▼ Sell | Open Market | 10,000 | $11K | 12/5/2025 |
| Alex P. Hamilton | ▼ Sell | Open Market | 125,000 | $153K | 11/19/2025 |
| Cohen Jacob D. | ▼ Sell | Gift | 500,000 | $0 | 9/30/2025 |
| Cohen Jacob D. | ▼ Sell | Gift | 500,000 | $0 | 9/30/2025 |
| Cohen Jacob D. | ▲ Buy | Grant | 500,000 | $0 | 9/9/2025 |
| JOHNSTON EUGENE M | ▲ Buy | Grant | 100,000 | $0 | 9/9/2025 |
| D'Alessio Lorraine Pamela | ▲ Buy | Grant | 100,000 | $0 | 9/9/2025 |
| Alex P. Hamilton | ▲ Buy | Grant | 100,000 | $0 | 9/9/2025 |
| MYERS KENNY | ▲ Buy | Grant | 100,000 | $0 | 9/9/2025 |
| Cohen Jacob D. | ▼ Sell | Gift | 200,000 | $0 | 6/5/2025 |
| Cohen Jacob D. | ▼ Sell | Gift | 200,000 | $0 | 6/5/2025 |
| Cohen Jacob D. | ▲ Buy | Grant | 200,000 | $0 | 4/10/2025 |
| MYERS KENNY | ▲ Buy | Grant | 25,000 | $0 | 4/10/2025 |
| D'Alessio Lorraine Pamela | ▲ Buy | Grant | 25,000 | $0 | 4/10/2025 |
| Cohen Jacob D. | ▲ Buy | Grant | 200,000 | $0 | 4/10/2025 |
| Alex P. Hamilton | ▲ Buy | Grant | 25,000 | $0 | 4/10/2025 |
| Isaac Antonios | ▲ Buy | Grant | 60,000 | $0 | 4/10/2025 |
| JOHNSTON EUGENE M | ▲ Buy | Grant | 25,000 | $0 | 11/11/2024 |
| Cohen Jacob D. | ▼ Sell | Gift | 800,000 | $0 | 8/26/2024 |
| Cohen Jacob D. | ▼ Sell | Gift | 800,000 | $0 | 8/26/2024 |
| Alex P. Hamilton | ▼ Sell | Open Market | 108,426 | $35K | 6/26/2024 |
| Alex P. Hamilton | ▼ Sell | Open Market | 16,574 | $5K | 6/25/2024 |
| Hammer Amanda Elizabeth | ▲ Buy | Grant | 100,000 | $0 | 6/3/2024 |
| Alex P. Hamilton | ▲ Buy | Grant | 100,000 | $0 | 6/3/2024 |
| MYERS KENNY | ▲ Buy | Grant | 100,000 | $0 | 6/3/2024 |
| Cohen Jacob D. | ▲ Buy | Grant | 800,000 | $0 | 6/3/2024 |
| D'Alessio Lorraine Pamela | ▲ Buy | Grant | 100,000 | $0 | 6/3/2024 |
| JOHNSTON EUGENE M | ▲ Buy | Grant | 50,000 | $0 | 10/3/2023 |
| Hammer Amanda Elizabeth | ▲ Buy | Grant | 75,000 | $0 | 5/1/2023 |
| Cohen Jacob D. | ▲ Buy | Open Market | 275,000 | $275K | 4/10/2023 |
| Cohen Jacob D. | ▼ Sell | Gift | 8,000,000 | $0 | 4/4/2023 |
| Cohen Jacob D. | ▼ Sell | Gift | 8,000,000 | $0 | 4/4/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
MGRX Shares Drop 12% After Hours Amid $2.5M Investment Announcement
Mangoceuticals shares fell 12% in after‑hours trading after the company announced a $2.5 million investment in its MangoRx IP. The deal provides an initial $1.75 million tranche and additional funding from strategic investors. Despite the funding, the market reacted negatively, pulling the stock lower. The move highlights the volatility around the company’s valuation.
MGRX Shares Drop 12% After Hours Amid $2.5M Investment Announcement. Mangoceuticals shares fell 12% in after‑hours trading after the company announced a $2.5 million investment in its MangoRx IP. The deal provides an initial $1.75 million tranche and additional funding from strategic investors. Despite the funding, the market reacted negatively, pulling the stock lower. The move highlights the volatility around the company’s valuation.